focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,028.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,028.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 17th Mar 2014 08:31

Admiral Group: Credit Suisse raises target price from 1340p to 1425p and keeps a neutral rating.African Barrick Gold: Canaccord Genuity ups target price from 315p to 330p and maintains a buy recommendation.Amara Mining: Canaccord Genuity moves target price from 25p to 33p and reiterates its buy recommendation.Avocet Mining: Canaccord Genuity shifts target price from 6p to 8p, but still recommends selling.Balfour Beatty: UBS moves target price from 250p to 260p, but still recommends selling.Barratt Developments: Deutsche Bank shifts target price from 452p to 453p keeping a buy recommendation.Bodycote: JP Morgan raises target price from 540p to 655p, while leaving its underweight rating unaltered.Burberry: Nomura ups target price from 1630p to 1650p and maintains a neutral rating.bwin.party: Citi cuts target price from 125p to 95p and downgrades from neutral to sell.Centamin: Canaccord Genuity moves target price from 53p to 68p and retains its speculative buy recommendation.Computacenter: Jefferies raises target price from 470p to 720p and retains a hold recommendation. Barclays initiates with a target price of 600p and an underweight rating.Gulf Keystone: Westhouse Securities cuts target price from 160p to 125p and maintains a neutral rating.Hellenic Carriers: Panmure Gordon moves target price from 50p to 60p and keeps a buy recommendation.Hikma Pharmaceuticals: Citi raises target price from 1700p to 1800p and reiterates a buy recommendation.Innovation Group: Investec shifts target price from 42p to 45p and keeps a buy recommendation.International Personal Finance: RBC Capital cuts target price from 595p to 575p and maintains an outperform rating.Micro Focus: Barclays upgrades to overweight with a target price of 900p.Minera IRL: Canaccord Genuity shifts target price from 19p to 20p and maintains its speculative buy recommendation.Moneysupermarket: Westhouse Securities shifts target price from 220p to 223p, while downgrading from buy to add.Morrison (Wm): Deutsche Bank upgrades to hold with a target price of 200p.Next: Jefferies raises target price from 7000p to 7500p and keeps a buy recommendation.Oxford Instruments: UBS reduces target price from 1750p to 1600p, while leaving its buy recommendation unaltered.Pan Africa Resources: Canaccord Genuity shifts target price from 16p to 18p and retains a buy recommendation.Petropavlovsk: Canaccord Genuity takes target price from 71p to 106p upgrading to buy. Polymetal International: Canaccord Genuity raises target price from 510p to 670p upgrading to buy.Provident Financial: RBC Capital increases target price from 1650p to 1875p maintaining a neutral rating.Randgold Resources: Canaccord Genuity raises target price from 3800p to 4800p and maintains a hold recommendation.Reed Elsevier: Berenberg takes target price from 895p to 930p, but downgrades from buy to hold.Regus: JP Morgan lowers target price from 177p to 174p and retains an underweight rating.Royal Dutch Shell: Credit Suisse raises target price from 2350p to 2450p and maintains an outperform rating.RPS Group: JP Morgan moves target price from 341p to 351p and reiterates an overweight rating.Salamander Energy: Deutsche Bank moves target price from 175p to 185p and retains a buy recommendation. Barclays cuts target price from 160p to 130p and keeps an equal-weight rating.Schroders: RBC Capital raises target price from 2550p to 2800p and stays with its neutral rating.Telit Communications: Canaccord Genuity ups target price from 230p to 245p staying with its buy recommendation.Tracsis: WH Ireland ups target price from 244p to 273p leaving its buy recommendation unchanged.Wolseley: Citi increases target price from 3596p to 3660p and maintains a buy recommendation.WPP Group: Liberum Capital reduces target price from 1600p to 1280p, while its hold recommendation remains unchanged.
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.